Susquehanna International Group, LLP Orgenesis Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.38 - $2.38 $40,391 - $69,660	29,269 New	29,269 $42,000
Q1 2022 May 16, 2022	SELL	$2.31 - $3.72 $28,644 - $46,128	-12,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.61 - $4.9 $32,364 - $60,760	12,400 New	12,400 $36,000
Q4 2019 Feb 14, 2020	SELL	$2.6 - $4.66 $34,447 - $61,740	-13,249 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.18 - $4.85 $55,380 - $64,257	13,249 New	13,249 $58,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.